TITLE

The potential role of appetite in predicting weight changes during treatment with olanzapine

AUTHOR(S)
Case, Michael; Treuer, Tamas; Karagianis, Jamie; Hoffmann, Vicki Poole
PUB. DATE
January 2010
SOURCE
BMC Psychiatry;2010, Vol. 10, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Clinically significant weight gain has been reported during treatment with atypical antipsychotics. It has been suggested that weight changes in patients treated with olanzapine may be associated with increased appetite. Methods: Data were used from adult patients for whom both appetite and weight data were available from 4 prospective, 12- to 24-week clinical trials. Patients' appetites were assessed with Eating Behavior Assessment (EBA, Study 1), Platypus Appetite Rating Scale (PARS, Study 2), Eating Inventory (EI, Study 3), Food Craving Inventory (FCI, Study 3), and Eating Attitude Scale (EAS, Study 4). Results: In Studies 1 (EBA) and 4 (EAS), patients who reported overall score increases on appetite scales, indicating an increase in appetite, experienced the greatest overall weight gains. However, in Studies 2 (PARS) and 3 (EI, FCI), patients who reported overall score increases on appetite scales did not experience greater weight changes than patients not reporting score increases. Early weight changes (2-4 weeks) were more positively correlated with overall weight changes than early or overall score changes on any utilized appetite assessment scale. No additional information was gained by adding early appetite change to early weight change in correlation to overall weight change. Conclusions: Early weight changes may be a more useful predictor for long-term weight changes than early score changes on appetite assessment scales. Clinical Trials Registration: This report represents secondary analyses of 4 clinical studies. Studies 1, 2, and 3 were registered at http://clinicaltrials.gov/ct2/home, under NCT00190749, NCT00303602, and NCT00401973, respectively. Study 4 predates the registration requirements for observational studies that are not classified as category 1 observational studies.
ACCESSION #
54098159

 

Related Articles

  • Sleep deprivation can put on the pounds.  // Consumer Reports on Health;Apr2005, Vol. 17 Issue 4, p7 

    The article reports that lack of sleep may encourage weight gain by intensifying your appetite. In a study of more than 900 people reported in January 2005, researchers at Eastern Virginia Medical School found that the less people slept each night, the more likely they were to be overweight. An...

  • Serum ghrelin concentrations in patients receiving olanzapine or risperidone. Togo, Takashi; Hasegawa, Koichi; Miura, Satoshi; Hosojima, Hideki; Kojima, Katsuo; Shoji, Mika; Kase, Akihiko; Uchikado, Hirotake; Iseki, Eizo; Kosaka, Kenji // Psychopharmacology;2004, Vol. 172 Issue 2, p230 

    Rationale. Although enhanced appetite and weight gain are potential side effects of treatment with antipsychotic agents, particularly olanzapine and clozapine, the mechanism is poorly understood. Objectives. To test the hypothesis that ghrelin, a gastrointestinal hormone that enhances appetite,...

  • Olanzapine, but Not Fluoxetine, Treatment Increases Survival in Activity-Based Anorexia in Mice. Klenotich, Stephanie J; Seiglie, Mariel P; McMurray, Matthew S; Roitman, Jamie D; Le Grange, Daniel; Dugad, Priya; Dulawa, Stephanie C // Neuropsychopharmacology;Jun2012, Vol. 37 Issue 7, p1620 

    Anorexia nervosa (AN) is an eating disorder characterized by extreme hypophagia, hyperactivity, and fear of weight gain. No approved pharmacological treatments exist for AN despite high mortality rates. The activity-based anorexia (ABA) phenomenon models aspects of AN in rodents, including...

  • Olanzapine.  // Reactions Weekly;8/18/2012, Issue 1415, p38 

    The article describes the case of a 32-year-old man with schizophrenia who developed weight gain while receiving olanzapine.

  • Olanzapine.  // Reactions Weekly;5/8/2010, Issue 1300, p37 

    The article describes four cases of patients who experienced weight gain while receiving olanzapine therapy.

  • Appetite Regulation: Hormones and Antipsychotics. Robinson, Donald S. // Primary Psychiatry;Feb2008, Vol. 15 Issue 2, p24 

    The article investigates the effects of antipsychotic therapy on appetite. It is noted that antipsychotics such as clozapine and olanzapine are prone to produce excessive weight gain. The effects of hormones ghrelin and leptin on appetite and weight control is discussed. It says first-generation...

  • Appetite hormones appear to be potential predictors of weight regain. Foster, Melissa; Kalvaitis, Katie; Shafer, Emily // Endocrine Today;Dec2010, Vol. 8 Issue 12, p32 

    The article discusses research on appetite hormones as a potential predictor of weight gain, referencing a study by A. B. Crujeras published in a 2010 issue of the "Journal of Clinical Endocrinology Metabolism."

  • stop gobbling your grub! Lofshult, Diane // IDEA Fitness Journal;May2010, Vol. 7 Issue 5, p46 

    The article reports on the results of a study on the impact of appetite and hormonal responses after meals on weight gain, published in the October 29, 2009 issue of the "Journal of Clinical Endocrinology & Metabolism."

  • Olanzapine.  // Reactions Weekly;6/18/2011, Issue 1356, p27 

    The article describes the case of a girl who gained weight following treatment with olanzapine for psychiatric disorders.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics